nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP2C9—Capecitabine—colon cancer	0.144	0.265	CbGbCtD
Terbinafine—CYP2C8—Fluorouracil—colon cancer	0.122	0.225	CbGbCtD
Terbinafine—CYP1A2—Fluorouracil—colon cancer	0.0948	0.174	CbGbCtD
Terbinafine—CYP2C9—Fluorouracil—colon cancer	0.0854	0.157	CbGbCtD
Terbinafine—CYP3A4—Irinotecan—colon cancer	0.0517	0.0952	CbGbCtD
Terbinafine—CYP3A4—Vincristine—colon cancer	0.0452	0.0832	CbGbCtD
Terbinafine—Hepatic enzyme increased—Methotrexate—colon cancer	0.00194	0.00453	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Capecitabine—colon cancer	0.00189	0.00443	CcSEcCtD
Terbinafine—Hypoaesthesia—Vincristine—colon cancer	0.00189	0.00442	CcSEcCtD
Terbinafine—Vasculitis—Methotrexate—colon cancer	0.00188	0.00439	CcSEcCtD
Terbinafine—Dermatitis bullous—Capecitabine—colon cancer	0.00187	0.00438	CcSEcCtD
Terbinafine—Connective tissue disorder—Vincristine—colon cancer	0.00186	0.00436	CcSEcCtD
Terbinafine—Agranulocytosis—Fluorouracil—colon cancer	0.00184	0.0043	CcSEcCtD
Terbinafine—Arthritis—Capecitabine—colon cancer	0.00184	0.0043	CcSEcCtD
Terbinafine—SQLE—digestive system—colon cancer	0.00182	0.0878	CbGeAlD
Terbinafine—Connective tissue disorder—Irinotecan—colon cancer	0.00181	0.00425	CcSEcCtD
Terbinafine—Visual impairment—Irinotecan—colon cancer	0.00178	0.00417	CcSEcCtD
Terbinafine—Hypoaesthesia—Fluorouracil—colon cancer	0.00176	0.00412	CcSEcCtD
Terbinafine—Skin exfoliation—Methotrexate—colon cancer	0.00175	0.00409	CcSEcCtD
Terbinafine—Angiopathy—Vincristine—colon cancer	0.00172	0.00403	CcSEcCtD
Terbinafine—Alopecia—Vincristine—colon cancer	0.00168	0.00392	CcSEcCtD
Terbinafine—Angiopathy—Irinotecan—colon cancer	0.00168	0.00392	CcSEcCtD
Terbinafine—Immune system disorder—Irinotecan—colon cancer	0.00167	0.0039	CcSEcCtD
Terbinafine—Mental disorder—Vincristine—colon cancer	0.00166	0.00389	CcSEcCtD
Terbinafine—Alopecia—Irinotecan—colon cancer	0.00163	0.00382	CcSEcCtD
Terbinafine—Abdominal pain upper—Capecitabine—colon cancer	0.00163	0.00382	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00161	0.00377	CcSEcCtD
Terbinafine—SQLE—vagina—colon cancer	0.00161	0.0775	CbGeAlD
Terbinafine—Nasopharyngitis—Capecitabine—colon cancer	0.0016	0.00374	CcSEcCtD
Terbinafine—Flatulence—Irinotecan—colon cancer	0.00158	0.00371	CcSEcCtD
Terbinafine—Gastritis—Capecitabine—colon cancer	0.00158	0.0037	CcSEcCtD
Terbinafine—Alopecia—Fluorouracil—colon cancer	0.00156	0.00366	CcSEcCtD
Terbinafine—Muscle spasms—Irinotecan—colon cancer	0.00155	0.00362	CcSEcCtD
Terbinafine—Influenza—Capecitabine—colon cancer	0.00154	0.00361	CcSEcCtD
Terbinafine—Erythema—Fluorouracil—colon cancer	0.00154	0.0036	CcSEcCtD
Terbinafine—Anaemia—Vincristine—colon cancer	0.00153	0.00357	CcSEcCtD
Terbinafine—Photosensitivity—Methotrexate—colon cancer	0.00151	0.00355	CcSEcCtD
Terbinafine—Ill-defined disorder—Irinotecan—colon cancer	0.00149	0.00349	CcSEcCtD
Terbinafine—Anaemia—Irinotecan—colon cancer	0.00149	0.00348	CcSEcCtD
Terbinafine—Vertigo—Vincristine—colon cancer	0.00148	0.00347	CcSEcCtD
Terbinafine—Abdominal discomfort—Capecitabine—colon cancer	0.00148	0.00347	CcSEcCtD
Terbinafine—Hepatic failure—Methotrexate—colon cancer	0.00148	0.00346	CcSEcCtD
Terbinafine—Pancytopenia—Capecitabine—colon cancer	0.00147	0.00343	CcSEcCtD
Terbinafine—Vision blurred—Fluorouracil—colon cancer	0.00145	0.0034	CcSEcCtD
Terbinafine—Malaise—Irinotecan—colon cancer	0.00145	0.00339	CcSEcCtD
Terbinafine—Vertigo—Irinotecan—colon cancer	0.00144	0.00338	CcSEcCtD
Terbinafine—Neutropenia—Capecitabine—colon cancer	0.00144	0.00338	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Capecitabine—colon cancer	0.00144	0.00336	CcSEcCtD
Terbinafine—Anaemia—Fluorouracil—colon cancer	0.00142	0.00333	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Methotrexate—colon cancer	0.00141	0.0033	CcSEcCtD
Terbinafine—Photosensitivity reaction—Capecitabine—colon cancer	0.00141	0.0033	CcSEcCtD
Terbinafine—Myalgia—Vincristine—colon cancer	0.00141	0.00329	CcSEcCtD
Terbinafine—Visual disturbance—Methotrexate—colon cancer	0.0014	0.00329	CcSEcCtD
Terbinafine—Cough—Irinotecan—colon cancer	0.0014	0.00328	CcSEcCtD
Terbinafine—Weight decreased—Capecitabine—colon cancer	0.0014	0.00327	CcSEcCtD
Terbinafine—Infestation NOS—Capecitabine—colon cancer	0.00138	0.00322	CcSEcCtD
Terbinafine—Infestation—Capecitabine—colon cancer	0.00138	0.00322	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Methotrexate—colon cancer	0.00137	0.00322	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00136	0.0032	CcSEcCtD
Terbinafine—SQLE—liver—colon cancer	0.00136	0.0654	CbGeAlD
Terbinafine—Discomfort—Irinotecan—colon cancer	0.00135	0.00317	CcSEcCtD
Terbinafine—Anaphylactic shock—Vincristine—colon cancer	0.00135	0.00315	CcSEcCtD
Terbinafine—Jaundice—Capecitabine—colon cancer	0.00134	0.00314	CcSEcCtD
Terbinafine—Infection—Vincristine—colon cancer	0.00134	0.00313	CcSEcCtD
Terbinafine—Confusional state—Irinotecan—colon cancer	0.00132	0.0031	CcSEcCtD
Terbinafine—Nervous system disorder—Vincristine—colon cancer	0.00132	0.00309	CcSEcCtD
Terbinafine—Thrombocytopenia—Vincristine—colon cancer	0.00132	0.00309	CcSEcCtD
Terbinafine—PTGS1—endothelium—colon cancer	0.00132	0.0636	CbGeAlD
Terbinafine—Anaphylactic shock—Irinotecan—colon cancer	0.00131	0.00307	CcSEcCtD
Terbinafine—Chest pain—Fluorouracil—colon cancer	0.00131	0.00307	CcSEcCtD
Terbinafine—Myalgia—Fluorouracil—colon cancer	0.00131	0.00307	CcSEcCtD
Terbinafine—Infection—Irinotecan—colon cancer	0.0013	0.00305	CcSEcCtD
Terbinafine—Hepatobiliary disease—Capecitabine—colon cancer	0.0013	0.00305	CcSEcCtD
Terbinafine—Discomfort—Fluorouracil—colon cancer	0.0013	0.00303	CcSEcCtD
Terbinafine—Nervous system disorder—Irinotecan—colon cancer	0.00129	0.00301	CcSEcCtD
Terbinafine—Agranulocytosis—Capecitabine—colon cancer	0.00128	0.00301	CcSEcCtD
Terbinafine—Thrombocytopenia—Irinotecan—colon cancer	0.00128	0.00301	CcSEcCtD
Terbinafine—Anorexia—Vincristine—colon cancer	0.00128	0.00301	CcSEcCtD
Terbinafine—Confusional state—Fluorouracil—colon cancer	0.00127	0.00297	CcSEcCtD
Terbinafine—Anaphylactic shock—Fluorouracil—colon cancer	0.00126	0.00294	CcSEcCtD
Terbinafine—Anorexia—Irinotecan—colon cancer	0.00125	0.00293	CcSEcCtD
Terbinafine—Infection—Fluorouracil—colon cancer	0.00125	0.00292	CcSEcCtD
Terbinafine—Hepatitis—Capecitabine—colon cancer	0.00124	0.00289	CcSEcCtD
Terbinafine—Nervous system disorder—Fluorouracil—colon cancer	0.00123	0.00288	CcSEcCtD
Terbinafine—Thrombocytopenia—Fluorouracil—colon cancer	0.00123	0.00288	CcSEcCtD
Terbinafine—Hypoaesthesia—Capecitabine—colon cancer	0.00123	0.00288	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00123	0.00287	CcSEcCtD
Terbinafine—PTGS1—blood vessel—colon cancer	0.00121	0.0586	CbGeAlD
Terbinafine—Connective tissue disorder—Capecitabine—colon cancer	0.00121	0.00284	CcSEcCtD
Terbinafine—Paraesthesia—Vincristine—colon cancer	0.00121	0.00283	CcSEcCtD
Terbinafine—Anorexia—Fluorouracil—colon cancer	0.0012	0.0028	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.0012	0.0028	CcSEcCtD
Terbinafine—Visual impairment—Capecitabine—colon cancer	0.00119	0.00279	CcSEcCtD
Terbinafine—Paraesthesia—Irinotecan—colon cancer	0.00118	0.00276	CcSEcCtD
Terbinafine—Decreased appetite—Vincristine—colon cancer	0.00117	0.00274	CcSEcCtD
Terbinafine—Erythema multiforme—Capecitabine—colon cancer	0.00117	0.00274	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Vincristine—colon cancer	0.00116	0.00272	CcSEcCtD
Terbinafine—Fatigue—Vincristine—colon cancer	0.00116	0.00272	CcSEcCtD
Terbinafine—Eye disorder—Capecitabine—colon cancer	0.00115	0.0027	CcSEcCtD
Terbinafine—Dyspepsia—Irinotecan—colon cancer	0.00115	0.0027	CcSEcCtD
Terbinafine—Tinnitus—Capecitabine—colon cancer	0.00115	0.0027	CcSEcCtD
Terbinafine—Pain—Vincristine—colon cancer	0.00115	0.0027	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00114	0.00268	CcSEcCtD
Terbinafine—Decreased appetite—Irinotecan—colon cancer	0.00114	0.00267	CcSEcCtD
Terbinafine—Eosinophilia—Methotrexate—colon cancer	0.00114	0.00266	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00113	0.00265	CcSEcCtD
Terbinafine—Fatigue—Irinotecan—colon cancer	0.00113	0.00265	CcSEcCtD
Terbinafine—Paraesthesia—Fluorouracil—colon cancer	0.00113	0.00264	CcSEcCtD
Terbinafine—Pancreatitis—Methotrexate—colon cancer	0.00113	0.00264	CcSEcCtD
Terbinafine—Pain—Irinotecan—colon cancer	0.00112	0.00263	CcSEcCtD
Terbinafine—Angiopathy—Capecitabine—colon cancer	0.00112	0.00263	CcSEcCtD
Terbinafine—Immune system disorder—Capecitabine—colon cancer	0.00112	0.00261	CcSEcCtD
Terbinafine—Dyspepsia—Fluorouracil—colon cancer	0.00111	0.00259	CcSEcCtD
Terbinafine—Abdominal discomfort—Methotrexate—colon cancer	0.0011	0.00258	CcSEcCtD
Terbinafine—Gastrointestinal pain—Vincristine—colon cancer	0.0011	0.00258	CcSEcCtD
Terbinafine—Decreased appetite—Fluorouracil—colon cancer	0.00109	0.00256	CcSEcCtD
Terbinafine—Alopecia—Capecitabine—colon cancer	0.00109	0.00256	CcSEcCtD
Terbinafine—Pancytopenia—Methotrexate—colon cancer	0.00109	0.00256	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00108	0.00254	CcSEcCtD
Terbinafine—Mental disorder—Capecitabine—colon cancer	0.00108	0.00253	CcSEcCtD
Terbinafine—Feeling abnormal—Irinotecan—colon cancer	0.00108	0.00253	CcSEcCtD
Terbinafine—Erythema—Capecitabine—colon cancer	0.00108	0.00252	CcSEcCtD
Terbinafine—Neutropenia—Methotrexate—colon cancer	0.00107	0.00252	CcSEcCtD
Terbinafine—Pain—Fluorouracil—colon cancer	0.00107	0.00252	CcSEcCtD
Terbinafine—Gastrointestinal pain—Irinotecan—colon cancer	0.00107	0.00251	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Methotrexate—colon cancer	0.00107	0.0025	CcSEcCtD
Terbinafine—Body temperature increased—Vincristine—colon cancer	0.00106	0.00249	CcSEcCtD
Terbinafine—Abdominal pain—Vincristine—colon cancer	0.00106	0.00249	CcSEcCtD
Terbinafine—Flatulence—Capecitabine—colon cancer	0.00106	0.00248	CcSEcCtD
Terbinafine—Dysgeusia—Capecitabine—colon cancer	0.00105	0.00247	CcSEcCtD
Terbinafine—Photosensitivity reaction—Methotrexate—colon cancer	0.00105	0.00246	CcSEcCtD
Terbinafine—SQLE—lymph node—colon cancer	0.00104	0.0502	CbGeAlD
Terbinafine—Body temperature increased—Irinotecan—colon cancer	0.00104	0.00243	CcSEcCtD
Terbinafine—Abdominal pain—Irinotecan—colon cancer	0.00104	0.00243	CcSEcCtD
Terbinafine—Feeling abnormal—Fluorouracil—colon cancer	0.00104	0.00242	CcSEcCtD
Terbinafine—Muscle spasms—Capecitabine—colon cancer	0.00103	0.00242	CcSEcCtD
Terbinafine—Infestation—Methotrexate—colon cancer	0.00102	0.0024	CcSEcCtD
Terbinafine—Infestation NOS—Methotrexate—colon cancer	0.00102	0.0024	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00102	0.00238	CcSEcCtD
Terbinafine—Vision blurred—Capecitabine—colon cancer	0.00101	0.00237	CcSEcCtD
Terbinafine—Ill-defined disorder—Capecitabine—colon cancer	0.000998	0.00234	CcSEcCtD
Terbinafine—Urticaria—Fluorouracil—colon cancer	0.000998	0.00234	CcSEcCtD
Terbinafine—Anaemia—Capecitabine—colon cancer	0.000994	0.00233	CcSEcCtD
Terbinafine—Body temperature increased—Fluorouracil—colon cancer	0.000993	0.00233	CcSEcCtD
Terbinafine—Hypersensitivity—Vincristine—colon cancer	0.000992	0.00232	CcSEcCtD
Terbinafine—Malaise—Capecitabine—colon cancer	0.00097	0.00227	CcSEcCtD
Terbinafine—Hepatobiliary disease—Methotrexate—colon cancer	0.000969	0.00227	CcSEcCtD
Terbinafine—Vertigo—Capecitabine—colon cancer	0.000967	0.00226	CcSEcCtD
Terbinafine—Hypersensitivity—Irinotecan—colon cancer	0.000967	0.00226	CcSEcCtD
Terbinafine—Asthenia—Vincristine—colon cancer	0.000967	0.00226	CcSEcCtD
Terbinafine—Agranulocytosis—Methotrexate—colon cancer	0.000956	0.00224	CcSEcCtD
Terbinafine—Asthenia—Irinotecan—colon cancer	0.000941	0.0022	CcSEcCtD
Terbinafine—Cough—Capecitabine—colon cancer	0.000939	0.0022	CcSEcCtD
Terbinafine—Hypersensitivity—Fluorouracil—colon cancer	0.000926	0.00217	CcSEcCtD
Terbinafine—Diarrhoea—Vincristine—colon cancer	0.000922	0.00216	CcSEcCtD
Terbinafine—Hepatitis—Methotrexate—colon cancer	0.00092	0.00215	CcSEcCtD
Terbinafine—Arthralgia—Capecitabine—colon cancer	0.000916	0.00214	CcSEcCtD
Terbinafine—Myalgia—Capecitabine—colon cancer	0.000916	0.00214	CcSEcCtD
Terbinafine—Chest pain—Capecitabine—colon cancer	0.000916	0.00214	CcSEcCtD
Terbinafine—Anxiety—Capecitabine—colon cancer	0.000913	0.00214	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00091	0.00213	CcSEcCtD
Terbinafine—Discomfort—Capecitabine—colon cancer	0.000905	0.00212	CcSEcCtD
Terbinafine—Diarrhoea—Irinotecan—colon cancer	0.000898	0.0021	CcSEcCtD
Terbinafine—Dry mouth—Capecitabine—colon cancer	0.000896	0.0021	CcSEcCtD
Terbinafine—Dizziness—Vincristine—colon cancer	0.000891	0.00209	CcSEcCtD
Terbinafine—Pruritus—Fluorouracil—colon cancer	0.000889	0.00208	CcSEcCtD
Terbinafine—Visual impairment—Methotrexate—colon cancer	0.000887	0.00208	CcSEcCtD
Terbinafine—Confusional state—Capecitabine—colon cancer	0.000885	0.00207	CcSEcCtD
Terbinafine—Infection—Capecitabine—colon cancer	0.000872	0.00204	CcSEcCtD
Terbinafine—Erythema multiforme—Methotrexate—colon cancer	0.00087	0.00204	CcSEcCtD
Terbinafine—Dizziness—Irinotecan—colon cancer	0.000868	0.00203	CcSEcCtD
Terbinafine—Nervous system disorder—Capecitabine—colon cancer	0.000861	0.00202	CcSEcCtD
Terbinafine—Eye disorder—Methotrexate—colon cancer	0.00086	0.00201	CcSEcCtD
Terbinafine—Diarrhoea—Fluorouracil—colon cancer	0.00086	0.00201	CcSEcCtD
Terbinafine—Thrombocytopenia—Capecitabine—colon cancer	0.00086	0.00201	CcSEcCtD
Terbinafine—Tinnitus—Methotrexate—colon cancer	0.000858	0.00201	CcSEcCtD
Terbinafine—Vomiting—Vincristine—colon cancer	0.000857	0.00201	CcSEcCtD
Terbinafine—Skin disorder—Capecitabine—colon cancer	0.000853	0.002	CcSEcCtD
Terbinafine—Rash—Vincristine—colon cancer	0.000849	0.00199	CcSEcCtD
Terbinafine—Dermatitis—Vincristine—colon cancer	0.000849	0.00199	CcSEcCtD
Terbinafine—Headache—Vincristine—colon cancer	0.000844	0.00198	CcSEcCtD
Terbinafine—Anorexia—Capecitabine—colon cancer	0.000837	0.00196	CcSEcCtD
Terbinafine—Angiopathy—Methotrexate—colon cancer	0.000835	0.00195	CcSEcCtD
Terbinafine—Vomiting—Irinotecan—colon cancer	0.000834	0.00195	CcSEcCtD
Terbinafine—Immune system disorder—Methotrexate—colon cancer	0.000831	0.00195	CcSEcCtD
Terbinafine—Dizziness—Fluorouracil—colon cancer	0.000831	0.00195	CcSEcCtD
Terbinafine—Rash—Irinotecan—colon cancer	0.000827	0.00194	CcSEcCtD
Terbinafine—Dermatitis—Irinotecan—colon cancer	0.000826	0.00193	CcSEcCtD
Terbinafine—Headache—Irinotecan—colon cancer	0.000822	0.00192	CcSEcCtD
Terbinafine—Alopecia—Methotrexate—colon cancer	0.000813	0.0019	CcSEcCtD
Terbinafine—Mental disorder—Methotrexate—colon cancer	0.000806	0.00189	CcSEcCtD
Terbinafine—Erythema—Methotrexate—colon cancer	0.000801	0.00187	CcSEcCtD
Terbinafine—Nausea—Vincristine—colon cancer	0.0008	0.00187	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.0008	0.00187	CcSEcCtD
Terbinafine—Vomiting—Fluorouracil—colon cancer	0.000799	0.00187	CcSEcCtD
Terbinafine—Rash—Fluorouracil—colon cancer	0.000792	0.00185	CcSEcCtD
Terbinafine—Dermatitis—Fluorouracil—colon cancer	0.000792	0.00185	CcSEcCtD
Terbinafine—Paraesthesia—Capecitabine—colon cancer	0.000788	0.00185	CcSEcCtD
Terbinafine—Headache—Fluorouracil—colon cancer	0.000787	0.00184	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—colon cancer	0.000784	0.00184	CcSEcCtD
Terbinafine—Nausea—Irinotecan—colon cancer	0.000779	0.00182	CcSEcCtD
Terbinafine—Dyspepsia—Capecitabine—colon cancer	0.000773	0.00181	CcSEcCtD
Terbinafine—Decreased appetite—Capecitabine—colon cancer	0.000763	0.00179	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000758	0.00177	CcSEcCtD
Terbinafine—Fatigue—Capecitabine—colon cancer	0.000757	0.00177	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—colon cancer	0.000755	0.00177	CcSEcCtD
Terbinafine—Pain—Capecitabine—colon cancer	0.000751	0.00176	CcSEcCtD
Terbinafine—Nausea—Fluorouracil—colon cancer	0.000746	0.00175	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—colon cancer	0.000743	0.00174	CcSEcCtD
Terbinafine—Anaemia—Methotrexate—colon cancer	0.00074	0.00173	CcSEcCtD
Terbinafine—Feeling abnormal—Capecitabine—colon cancer	0.000724	0.00169	CcSEcCtD
Terbinafine—Malaise—Methotrexate—colon cancer	0.000722	0.00169	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—colon cancer	0.00072	0.00168	CcSEcCtD
Terbinafine—Gastrointestinal pain—Capecitabine—colon cancer	0.000718	0.00168	CcSEcCtD
Terbinafine—Cough—Methotrexate—colon cancer	0.000699	0.00164	CcSEcCtD
Terbinafine—Urticaria—Capecitabine—colon cancer	0.000698	0.00163	CcSEcCtD
Terbinafine—Body temperature increased—Capecitabine—colon cancer	0.000694	0.00162	CcSEcCtD
Terbinafine—Abdominal pain—Capecitabine—colon cancer	0.000694	0.00162	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—colon cancer	0.000682	0.0016	CcSEcCtD
Terbinafine—Myalgia—Methotrexate—colon cancer	0.000682	0.0016	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—colon cancer	0.000682	0.0016	CcSEcCtD
Terbinafine—CYP11A1—lymph node—colon cancer	0.000681	0.0329	CbGeAlD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000677	0.00159	CcSEcCtD
Terbinafine—CYP2C8—renal system—colon cancer	0.000676	0.0326	CbGeAlD
Terbinafine—Discomfort—Methotrexate—colon cancer	0.000674	0.00158	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—colon cancer	0.000659	0.00154	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—colon cancer	0.000654	0.00153	CcSEcCtD
Terbinafine—Infection—Methotrexate—colon cancer	0.000649	0.00152	CcSEcCtD
Terbinafine—Hypersensitivity—Capecitabine—colon cancer	0.000647	0.00151	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—colon cancer	0.000641	0.0015	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—colon cancer	0.00064	0.0015	CcSEcCtD
Terbinafine—CYP2C19—digestive system—colon cancer	0.000635	0.0307	CbGeAlD
Terbinafine—Skin disorder—Methotrexate—colon cancer	0.000635	0.00149	CcSEcCtD
Terbinafine—CYP1A2—renal system—colon cancer	0.000633	0.0305	CbGeAlD
Terbinafine—Asthenia—Capecitabine—colon cancer	0.00063	0.00147	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—colon cancer	0.000623	0.00146	CcSEcCtD
Terbinafine—Pruritus—Capecitabine—colon cancer	0.000621	0.00145	CcSEcCtD
Terbinafine—Diarrhoea—Capecitabine—colon cancer	0.000601	0.00141	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000596	0.00139	CcSEcCtD
Terbinafine—PTGS1—epithelium—colon cancer	0.000591	0.0285	CbGeAlD
Terbinafine—Paraesthesia—Methotrexate—colon cancer	0.000587	0.00137	CcSEcCtD
Terbinafine—Dizziness—Capecitabine—colon cancer	0.000581	0.00136	CcSEcCtD
Terbinafine—CYP19A1—liver—colon cancer	0.000577	0.0279	CbGeAlD
Terbinafine—Dyspepsia—Methotrexate—colon cancer	0.000575	0.00135	CcSEcCtD
Terbinafine—PTGS1—smooth muscle tissue—colon cancer	0.00057	0.0275	CbGeAlD
Terbinafine—Decreased appetite—Methotrexate—colon cancer	0.000568	0.00133	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000564	0.00132	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—colon cancer	0.000564	0.00132	CcSEcCtD
Terbinafine—CYP2C19—vagina—colon cancer	0.000561	0.0271	CbGeAlD
Terbinafine—Pain—Methotrexate—colon cancer	0.000559	0.00131	CcSEcCtD
Terbinafine—Vomiting—Capecitabine—colon cancer	0.000558	0.00131	CcSEcCtD
Terbinafine—Rash—Capecitabine—colon cancer	0.000554	0.0013	CcSEcCtD
Terbinafine—Dermatitis—Capecitabine—colon cancer	0.000553	0.00129	CcSEcCtD
Terbinafine—Headache—Capecitabine—colon cancer	0.00055	0.00129	CcSEcCtD
Terbinafine—PTGS1—renal system—colon cancer	0.000548	0.0265	CbGeAlD
Terbinafine—Feeling abnormal—Methotrexate—colon cancer	0.000539	0.00126	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—colon cancer	0.000534	0.00125	CcSEcCtD
Terbinafine—CYP11A1—Metapathway biotransformation—CHST4—colon cancer	0.000534	0.0623	CbGpPWpGaD
Terbinafine—Nausea—Capecitabine—colon cancer	0.000522	0.00122	CcSEcCtD
Terbinafine—Urticaria—Methotrexate—colon cancer	0.000519	0.00122	CcSEcCtD
Terbinafine—CYP1A2—digestive system—colon cancer	0.000519	0.0251	CbGeAlD
Terbinafine—Body temperature increased—Methotrexate—colon cancer	0.000517	0.00121	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—colon cancer	0.000517	0.00121	CcSEcCtD
Terbinafine—CYP2C9—digestive system—colon cancer	0.000493	0.0238	CbGeAlD
Terbinafine—CYP2C8—vagina—colon cancer	0.00049	0.0236	CbGeAlD
Terbinafine—Hypersensitivity—Methotrexate—colon cancer	0.000482	0.00113	CcSEcCtD
Terbinafine—CYP2C19—liver—colon cancer	0.000473	0.0229	CbGeAlD
Terbinafine—Asthenia—Methotrexate—colon cancer	0.000469	0.0011	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—colon cancer	0.000462	0.00108	CcSEcCtD
Terbinafine—CYP3A4—renal system—colon cancer	0.000458	0.0221	CbGeAlD
Terbinafine—CYP2D6—renal system—colon cancer	0.000451	0.0218	CbGeAlD
Terbinafine—PTGS1—digestive system—colon cancer	0.00045	0.0217	CbGeAlD
Terbinafine—Diarrhoea—Methotrexate—colon cancer	0.000447	0.00105	CcSEcCtD
Terbinafine—CYP19A1—lymph node—colon cancer	0.000443	0.0214	CbGeAlD
Terbinafine—Dizziness—Methotrexate—colon cancer	0.000432	0.00101	CcSEcCtD
Terbinafine—Vomiting—Methotrexate—colon cancer	0.000416	0.000973	CcSEcCtD
Terbinafine—CYP2C8—liver—colon cancer	0.000413	0.0199	CbGeAlD
Terbinafine—Rash—Methotrexate—colon cancer	0.000412	0.000965	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—colon cancer	0.000412	0.000964	CcSEcCtD
Terbinafine—Headache—Methotrexate—colon cancer	0.000409	0.000959	CcSEcCtD
Terbinafine—PTGS1—vagina—colon cancer	0.000397	0.0192	CbGeAlD
Terbinafine—Nausea—Methotrexate—colon cancer	0.000388	0.000909	CcSEcCtD
Terbinafine—CYP1A2—liver—colon cancer	0.000387	0.0187	CbGeAlD
Terbinafine—CYP3A4—digestive system—colon cancer	0.000376	0.0181	CbGeAlD
Terbinafine—CYP2D6—digestive system—colon cancer	0.00037	0.0178	CbGeAlD
Terbinafine—CYP2C9—liver—colon cancer	0.000367	0.0177	CbGeAlD
Terbinafine—CYP19A1—Metapathway biotransformation—CHST4—colon cancer	0.000353	0.0412	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.000301	0.0352	CbGpPWpGaD
Terbinafine—CYP3A4—liver—colon cancer	0.00028	0.0135	CbGeAlD
Terbinafine—CYP2D6—liver—colon cancer	0.000275	0.0133	CbGeAlD
Terbinafine—PTGS1—lymph node—colon cancer	0.000257	0.0124	CbGeAlD
Terbinafine—CYP19A1—Ovarian Infertility Genes—MLH1—colon cancer	0.000252	0.0293	CbGpPWpGaD
Terbinafine—CYP11A1—Metapathway biotransformation—CHST5—colon cancer	0.000245	0.0286	CbGpPWpGaD
Terbinafine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000226	0.0264	CbGpPWpGaD
Terbinafine—SQLE—SREBP signalling—PPARG—colon cancer	0.000219	0.0256	CbGpPWpGaD
Terbinafine—PTGS1—Overview of nanoparticle effects—BAX—colon cancer	0.000202	0.0235	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—CHST4—colon cancer	0.000192	0.0224	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.000183	0.0213	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CHST4—colon cancer	0.000172	0.02	CbGpPWpGaD
Terbinafine—CYP19A1—Metapathway biotransformation—CHST5—colon cancer	0.000162	0.0189	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—CA7—colon cancer	0.000162	0.0189	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	0.000158	0.0184	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	0.000156	0.0182	CbGpPWpGaD
Terbinafine—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—colon cancer	0.000149	0.0174	CbGpPWpGaD
Terbinafine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000148	0.0172	CbGpPWpGaD
Terbinafine—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	0.000145	0.0169	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—CHST4—colon cancer	0.000134	0.0156	CbGpPWpGaD
Terbinafine—PTGS1—Overview of nanoparticle effects—PTGS2—colon cancer	0.000117	0.0136	CbGpPWpGaD
Terbinafine—SQLE—SREBP signalling—PIK3CA—colon cancer	0.000106	0.0124	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000103	0.012	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—MSH6—colon cancer	9.94e-05	0.0116	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—CHST5—colon cancer	9.82e-05	0.0115	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—ODC1—colon cancer	9.82e-05	0.0115	CbGpPWpGaD
Terbinafine—PTGS1—Eicosanoid Synthesis—PTGS2—colon cancer	9.68e-05	0.0113	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	8.82e-05	0.0103	CbGpPWpGaD
Terbinafine—SQLE—SREBP signalling—AKT1—colon cancer	8.67e-05	0.0101	CbGpPWpGaD
Terbinafine—CYP19A1—FSH signaling pathway—SRC—colon cancer	8.47e-05	0.00988	CbGpPWpGaD
Terbinafine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	8.1e-05	0.00945	CbGpPWpGaD
Terbinafine—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	8.1e-05	0.00945	CbGpPWpGaD
Terbinafine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	8.08e-05	0.00943	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—MSH2—colon cancer	8.07e-05	0.00941	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	7.88e-05	0.00919	CbGpPWpGaD
Terbinafine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	7.39e-05	0.00862	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—BRAF—colon cancer	7.34e-05	0.00856	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	7.24e-05	0.00845	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	7.18e-05	0.00838	CbGpPWpGaD
Terbinafine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	7.04e-05	0.00821	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CA7—colon cancer	7.01e-05	0.00818	CbGpPWpGaD
Terbinafine—CYP3A4—Irinotecan Pathway—APC—colon cancer	6.8e-05	0.00794	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	6.14e-05	0.00716	CbGpPWpGaD
Terbinafine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.01e-05	0.00702	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—CASP3—colon cancer	5.5e-05	0.00642	CbGpPWpGaD
Terbinafine—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	5.38e-05	0.00628	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—CTNNB1—colon cancer	5.3e-05	0.00619	CbGpPWpGaD
Terbinafine—CYP19A1—FSH signaling pathway—AKT1—colon cancer	5.26e-05	0.00614	CbGpPWpGaD
Terbinafine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.9e-05	0.00571	CbGpPWpGaD
Terbinafine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	4.87e-05	0.00568	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	4.74e-05	0.00553	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CA7—colon cancer	4.64e-05	0.00542	CbGpPWpGaD
Terbinafine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	4.64e-05	0.00542	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—BAX—colon cancer	4.57e-05	0.00533	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	4.47e-05	0.00521	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—TGFB1—colon cancer	4.28e-05	0.005	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CHST5—colon cancer	4.25e-05	0.00496	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ODC1—colon cancer	4.25e-05	0.00496	CbGpPWpGaD
Terbinafine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.18e-05	0.00488	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.05e-05	0.00473	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CA7—colon cancer	3.91e-05	0.00456	CbGpPWpGaD
Terbinafine—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	3.48e-05	0.00406	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	3.42e-05	0.00399	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—BRAF—colon cancer	3.27e-05	0.00381	CbGpPWpGaD
Terbinafine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.23e-05	0.00377	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CDH1—colon cancer	3.2e-05	0.00374	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.19e-05	0.00372	CbGpPWpGaD
Terbinafine—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	3.1e-05	0.00362	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—AKT1—colon cancer	2.98e-05	0.00348	CbGpPWpGaD
Terbinafine—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	2.83e-05	0.0033	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CHST5—colon cancer	2.81e-05	0.00328	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ODC1—colon cancer	2.81e-05	0.00328	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.65e-05	0.00309	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—ABCB1—colon cancer	2.6e-05	0.00303	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	2.58e-05	0.00302	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—TYMS—colon cancer	2.55e-05	0.00297	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CA7—colon cancer	2.53e-05	0.00295	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	2.45e-05	0.00286	CbGpPWpGaD
Terbinafine—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	2.42e-05	0.00282	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	2.39e-05	0.00278	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ODC1—colon cancer	2.37e-05	0.00276	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CHST5—colon cancer	2.37e-05	0.00276	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	2.36e-05	0.00276	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	2.26e-05	0.00264	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CA7—colon cancer	2.25e-05	0.00263	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	2.2e-05	0.00256	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	2.15e-05	0.00251	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	2.15e-05	0.00251	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	2.09e-05	0.00244	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	2.09e-05	0.00244	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	2.08e-05	0.00243	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CA7—colon cancer	2.07e-05	0.00242	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CA7—colon cancer	2.06e-05	0.0024	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	2.04e-05	0.00238	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	2.01e-05	0.00235	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.96e-05	0.00229	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	1.91e-05	0.00223	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	1.87e-05	0.00219	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	1.87e-05	0.00218	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	1.87e-05	0.00218	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	1.83e-05	0.00214	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	1.83e-05	0.00214	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PPARG—colon cancer	1.81e-05	0.00211	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	1.77e-05	0.00206	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CA7—colon cancer	1.76e-05	0.00205	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.75e-05	0.00205	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	1.73e-05	0.00202	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	1.57e-05	0.00183	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ODC1—colon cancer	1.53e-05	0.00179	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CHST5—colon cancer	1.53e-05	0.00179	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.47e-05	0.00172	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PTGS2—colon cancer	1.42e-05	0.00166	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.38e-05	0.00161	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ODC1—colon cancer	1.37e-05	0.00159	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CHST5—colon cancer	1.37e-05	0.00159	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CA7—colon cancer	1.36e-05	0.00158	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	1.33e-05	0.00155	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CHST5—colon cancer	1.26e-05	0.00147	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ODC1—colon cancer	1.26e-05	0.00147	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CHST5—colon cancer	1.25e-05	0.00145	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ODC1—colon cancer	1.25e-05	0.00145	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—EP300—colon cancer	1.18e-05	0.00138	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.16e-05	0.00136	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.15e-05	0.00134	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ABCB1—colon cancer	1.12e-05	0.00131	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—TYMS—colon cancer	1.1e-05	0.00129	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CHST5—colon cancer	1.06e-05	0.00124	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ODC1—colon cancer	1.06e-05	0.00124	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.78e-06	0.00114	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.14e-06	0.00107	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PIK3CA—colon cancer	8.74e-06	0.00102	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.49e-06	0.00099	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CHST5—colon cancer	8.21e-06	0.000958	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ODC1—colon cancer	8.21e-06	0.000958	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PPARG—colon cancer	7.81e-06	0.000911	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.69e-06	0.000897	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.6e-06	0.000887	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ABCB1—colon cancer	7.44e-06	0.000868	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—TYMS—colon cancer	7.3e-06	0.000852	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—AKT1—colon cancer	7.14e-06	0.000833	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.4e-06	0.000746	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.32e-06	0.000737	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ABCB1—colon cancer	6.26e-06	0.00073	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—TYMS—colon cancer	6.15e-06	0.000717	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTGS2—colon cancer	6.14e-06	0.000717	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.64e-06	0.000658	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.62e-06	0.000656	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPARG—colon cancer	5.17e-06	0.000604	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.14e-06	0.0006	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—EP300—colon cancer	5.11e-06	0.000596	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.97e-06	0.00058	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.73e-06	0.000552	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.43e-06	0.000517	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.39e-06	0.000513	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARG—colon cancer	4.35e-06	0.000508	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.13e-06	0.000482	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTGS2—colon cancer	4.07e-06	0.000475	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.04e-06	0.000472	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ABCB1—colon cancer	4.04e-06	0.000472	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—TYMS—colon cancer	3.97e-06	0.000463	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CA—colon cancer	3.78e-06	0.000441	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.69e-06	0.00043	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ABCB1—colon cancer	3.61e-06	0.000421	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—TYMS—colon cancer	3.54e-06	0.000414	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.46e-06	0.000403	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTGS2—colon cancer	3.43e-06	0.0004	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—EP300—colon cancer	3.38e-06	0.000395	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.36e-06	0.000392	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ABCB1—colon cancer	3.32e-06	0.000387	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ABCB1—colon cancer	3.29e-06	0.000384	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—TYMS—colon cancer	3.26e-06	0.00038	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—TYMS—colon cancer	3.23e-06	0.000377	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—colon cancer	3.09e-06	0.00036	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.06e-06	0.000357	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.87e-06	0.000335	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—EP300—colon cancer	2.85e-06	0.000332	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARG—colon cancer	2.81e-06	0.000328	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ABCB1—colon cancer	2.81e-06	0.000328	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TYMS—colon cancer	2.76e-06	0.000322	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.73e-06	0.000318	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARG—colon cancer	2.51e-06	0.000293	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CA—colon cancer	2.5e-06	0.000292	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.49e-06	0.00029	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARG—colon cancer	2.31e-06	0.000269	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARG—colon cancer	2.29e-06	0.000267	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTGS2—colon cancer	2.21e-06	0.000258	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCB1—colon cancer	2.17e-06	0.000253	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TYMS—colon cancer	2.13e-06	0.000249	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.13e-06	0.000248	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CA—colon cancer	2.11e-06	0.000246	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—colon cancer	2.05e-06	0.000239	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTGS2—colon cancer	1.98e-06	0.00023	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARG—colon cancer	1.96e-06	0.000228	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—EP300—colon cancer	1.84e-06	0.000215	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTGS2—colon cancer	1.82e-06	0.000212	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTGS2—colon cancer	1.8e-06	0.00021	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—colon cancer	1.72e-06	0.000201	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—EP300—colon cancer	1.64e-06	0.000192	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTGS2—colon cancer	1.54e-06	0.00018	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—EP300—colon cancer	1.51e-06	0.000176	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARG—colon cancer	1.51e-06	0.000176	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—EP300—colon cancer	1.5e-06	0.000175	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CA—colon cancer	1.36e-06	0.000159	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—EP300—colon cancer	1.28e-06	0.000149	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CA—colon cancer	1.22e-06	0.000142	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTGS2—colon cancer	1.19e-06	0.000139	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.12e-06	0.00013	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—colon cancer	1.11e-06	0.00013	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CA—colon cancer	1.11e-06	0.000129	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—colon cancer	9.93e-07	0.000116	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—EP300—colon cancer	9.88e-07	0.000115	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CA—colon cancer	9.47e-07	0.00011	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—colon cancer	9.13e-07	0.000107	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—colon cancer	9.05e-07	0.000106	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—colon cancer	7.73e-07	9.02e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CA—colon cancer	7.31e-07	8.53e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—colon cancer	5.97e-07	6.96e-05	CbGpPWpGaD
